The role of surgery in locally advanced carcinoma of cervix after sub-optimal chemoradiation: Indian scenario
- PMID: 24455590
- PMCID: PMC3892514
- DOI: 10.4103/2278-330X.114119
The role of surgery in locally advanced carcinoma of cervix after sub-optimal chemoradiation: Indian scenario
Abstract
Background: Standard treatment of advanced cervical cancer is concurrent chemoradiation. Radical radiotherapy for carcinoma cervix includes pelvic external beam radiotherapy (EBRT) with the concomitant platinum based chemotherapy followed by intracavitary brachytherapy (ICBT) to boost central disease. Management of patients who are suboptimally treated, especially, after unsuccessful ICBT insertion is not well-defined. This study explores the role of hysterectomy in these patients.
Materials and methods: From January 2006 to December 2011, 38 patients with locally advanced cervical cancer, in whom ICBT insertion was unsuccessful, were analyzed retrospectively. Operable patients with no parametrial involvement underwent hysterectomy and outcomes (recurrence free and overall survival) were noted.
Results: The major complications in post operative period were wound infection, paralytic ileus and bladder atony all of which were conservatively managed with no mortality. At median follow-up of 36 months (range 12-60 months) there was no recurrence in patients with stage 1B2 and stage IIA, 25 out of 38 (65.8%) were event free and the overall survival was 71%.
Conclusion: Many patients in Indian scenario receive suboptimal therapy in locally advanced cervical cancer. EBRT with chemotherapy followed by type 1 extra-fascial hysterectomy can be a good alternative for these patients.
Keywords: Carcinoma cervix; hysterectomy; unsuccessful intracavitary brachytherapy.
Conflict of interest statement
Figures
Similar articles
-
Is there a role for adjuvant hysterectomy after suboptimal concurrent chemoradiation in cervical carcinoma?Clin Oncol (R Coll Radiol). 2010 Mar;22(2):140-6. doi: 10.1016/j.clon.2009.11.006. Epub 2010 Jan 4. Clin Oncol (R Coll Radiol). 2010. PMID: 20045300
-
Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1508-15. doi: 10.1016/j.ijrobp.2008.03.054. Int J Radiat Oncol Biol Phys. 2008. PMID: 18676093
-
[Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].Cancer Radiother. 2004 Jun;8(3):168-77. doi: 10.1016/j.canrad.2004.02.002. Cancer Radiother. 2004. PMID: 15217584 Clinical Trial. French.
-
Concurrent Taxol-Based Doublet Chemotherapy as an Alternative for Intracavitary Brachytherapy Boost in Locally Advanced Carcinoma Cervix- Retrospective Analysis From a Tertiary Care Center.Cureus. 2021 Jul 11;13(7):e16313. doi: 10.7759/cureus.16313. eCollection 2021 Jul. Cureus. 2021. PMID: 34277305 Free PMC article.
-
Cervical cancer: combined modality therapy.Cancer J. 2001 Jul-Aug;7 Suppl 1:S47-50. Cancer J. 2001. PMID: 11504285 Review.
Cited by
-
IMRT as an Alternative Technique for Intracavitary Brachytherapy in Patients with Carcinoma of the Cervix: A Feasibility Study Using Unified Dosimetric Index.Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3563-3568. doi: 10.31557/APJCP.2023.24.10.3563. Asian Pac J Cancer Prev. 2023. PMID: 37898864 Free PMC article.
-
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD010260. doi: 10.1002/14651858.CD010260.pub3. Cochrane Database Syst Rev. 2022. PMID: 35994243 Free PMC article.
-
Epidemiology of human papillomavirus related cancers in India: findings from the National Cancer Registry Programme.Ecancermedicalscience. 2022 Sep 7;16:1444. doi: 10.3332/ecancer.2022.1444. eCollection 2022. Ecancermedicalscience. 2022. PMID: 36405943 Free PMC article.
-
Adjuvant Hysterectomy in Patients With Residual Disease After Radiation for Locally Advanced Cervical Cancer: A Prospective Longitudinal Study.J Glob Oncol. 2019 Jan;5:1-7. doi: 10.1200/JGO.18.00157. J Glob Oncol. 2019. PMID: 30707665 Free PMC article.
-
Harnessing the Potential of Plant Expression System towards the Production of Vaccines for the Prevention of Human Papillomavirus and Cervical Cancer.Vaccines (Basel). 2022 Dec 1;10(12):2064. doi: 10.3390/vaccines10122064. Vaccines (Basel). 2022. PMID: 36560473 Free PMC article. Review.
References
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet. 2001;358:781–6. - PubMed
-
- Coia L, Won M, Lanciano R, Marcial VA, Martz K, Hanks G. The Patterns of Care Outcome Study for cancer of the uterine cervix. Results of the Second National Practice Survey. Cancer. 1990;66:2451–6. - PubMed
-
- Logsdon MD, Eifel PJ. Figo IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys. 1999;43:763–75. - PubMed
-
- Walji N, Chue AL, Yap C, Rogers LJ, El-Modir A, Chan KK, et al. Is there a role for adjuvant hysterectomy after suboptimal concurrent chemoradiation in cervical carcinoma? Clin Oncol (R Coll Radiol) 2010;22:140–6. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources